Cargando…

S90. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PHARMACOLOGICAL INTERVENTIONS FOR REDUCTION OF WEIGHT GAIN IN PEOPLE WITH SCHIZOPHRENIA: 2019 UPDATE

BACKGROUND: Weight gain and obesity are common problems encountered by patients with schizophrenia. This is partially attributable to use of second-generation antipsychotics that are associated with weight gain and other metabolic disturbances. The significance of this prevalence and its impact on p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Sri Mahavir, Stogios, Nicolette, Ahsan, Zohra, Lockwood, Jonathan, Duncan, Markus, Takeuchi, Hiroyoshi, Cohn, Tony, Taylor, Valerie, Remington, Gary, Faulkner, Guy, Hahn, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234538/ http://dx.doi.org/10.1093/schbul/sbaa031.156

Ejemplares similares

S225. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PHARMACOLOGICAL INTERVENTIONS FOR REDUCTION OR PREVENTION OF WEIGHT GAIN IN SCHIZOPHRENIA
por: Agarwal, Sri Mahavir, et al.
Publicado: (2018)

S89. INVESTIGATING METABOLIC DYSFUNCTION AND METABOLOMIC PROFILE CHANGES IN ANTIPSYCHOTIC NAIVE PATIENTS
por: Costa-Dookhan, Kenya, et al.
Publicado: (2020)

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
por: Stogios, Nicolette, et al.
Publicado: (2021)

S195. ROLE OF BOOSTER SESSION TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS) FOR PERSISTENT AUDITORY HALLUCINATIONS IN SCHIZOPHRENIA
por: Parlikar, Rujuta, et al.
Publicado: (2020)

Non-invasive neuromodulation of dorsolateral prefrontal cortex to reduce craving in alcohol use disorder: A meta-analysis
por: Sorkhou, Maryam, et al.
Publicado: (2022)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

S119. A DIMENSIONAL APPROACH TO UNDERSTANDING COST-BENEFIT DECISION-MAKING IN SCHIZOPHRENIA AND DEPRESSION
por: Saperia, Sarah, et al.
Publicado: (2020)

S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020)

S213. CIRCADIAN PATTERNS OF HALLUCINATORY EXPERIENCES IN PATIENTS WITH SCHIZOPHRENIA: POTENTIALS FOR CHRONO-PHARMACOLOGY
Publicado: (2020)

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
por: Singh, Raghunath, et al.
Publicado: (2022)

Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
por: Stogios, Nicolette, et al.
Publicado: (2022)

Favourable cognitive changes observed with metabolic improvements in a patient with severe mental illness
por: van Reekum, Emma A, et al.
Publicado: (2023)

T231. QUALITY OF LIFE IN ANTIPSYCHOTIC-NAïVE YOUTH: EXPLORING THE INTERPLAY WITH METABOLIC SIDE-EFFECTS
por: Chintoh, Araba, et al.
Publicado: (2020)

M84. METFORMIN FOR EARLY CO-MORBID PREDIABETES OR DIABETES IN SCHIZOPHRENIA SPECTRUM DISORDERS: A DOUBLE BLIND RANDOMIZED PILOT STUDY
por: Mahavir Agarwal, Sri, et al.
Publicado: (2020)

S156. PUBLIC ATTENTION TO CRIME OF SCHIZOPHRENIA AND ITS CORRELATION WITH USE OF MENTAL HEALTH SERVICES IN PATIENTS WITH SCHIZOPHRENIA
por: Park, Hyunwoo, et al.
Publicado: (2020)

S91. OPIOID USE AND SCHIZOPHRENIA: AN UPDATE
Publicado: (2020)

S209. DRUG-NAïVE FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDERS: PHARMACOLOGICAL TREATMENT PRACTICES IN INPATIENT UNITS IN HUNAN PROVINCE, CHINA
por: Zhu, Mengran, et al.
Publicado: (2020)

S198. SELF-DISTURBANCES AND THEIR NEURAL SIGNATURES IN SCHIZOPHRENIA
por: Zaytseva, Yulia, et al.
Publicado: (2020)

S155. DIETARY PATTERNS AND OBESITY IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Amirah Abdul Rashid, Nur, et al.
Publicado: (2020)

S142. NOVEL CONCEPTS OF SOCIAL IMPAIRMENTS IN SCHIZOPHRENIA
por: Bitsch, Florian, et al.
Publicado: (2020)

S158. URBANICITY INDEX AND CORTICAL GYRIFICATION IN SCHIZOPHRENIA
por: Korann, Vittal, et al.
Publicado: (2020)

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020)

Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis
por: Wu, Sally, et al.
Publicado: (2023)

S237. MODERATORS AND RELATIONSHIPS OF COGNITION AND SUBJECTIVE QUALITY OF LIFE IN SCHIZOPHRENIA
por: Tan, Eric, et al.
Publicado: (2020)

S223. DETERMINANTS OF SUSTAINED UNEMPLOYMENT IN FORMERLY EMPLOYED SCHIZOPHRENIA PATIENTS
por: Fundora-Trujillo, Cynthia, et al.
Publicado: (2020)

S233. INTERNALIZED STIGMA IN PATIENTS WITH SCHIZOPHRENIA - A TRANSCULTURAL STUDY
Publicado: (2020)

S66. USING UNITIZATION TO CIRCUMVENT RELATIONAL MEMORY DEFICITS IN SCHIZOPHRENIA
por: de Sousa, Ana Elisa Farias, et al.
Publicado: (2020)

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?
por: Breier, Alan, et al.
Publicado: (2020)

S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Jeong Park, Kee, et al.
Publicado: (2020)

S149. CHANGES IN FRONTO-PARIETAL CONNECTIVITY IN SCHIZOPHRENIA: TMS AND FNIRS STUDY
por: Ćurčić-Blake, Branislava, et al.
Publicado: (2020)

S168. THE ASSOCIATION BETWEEN MMP-9 AND CHOROID PLEXUS VOLUME IN SCHIZOPHRENIA
por: Seethaler, Magdalena, et al.
Publicado: (2020)

S97. IS EARLY DEBUT OF SUBSTANCE USE ASSOCIATED WITH VIOLENT OFFENDING IN SCHIZOPHRENIA?
por: Breivik Storvestre, Guttorm, et al.
Publicado: (2020)

S116. PRAGMATIC COMPREHENSION IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Parola, Alberto, et al.
Publicado: (2020)

S190. WHEN WORDS AREN’T ENOUGH: DANCE/MOVEMENT THERAPY AND SCHIZOPHRENIA
por: Biondo, Jacelyn, et al.
Publicado: (2020)

S191. A SCOPING REVIEW AND PHENOMENOLOGICAL EVALUATION OF METACOGNITIVE TRAINING FOR SCHIZOPHRENIA
por: Brar, Pavan, et al.
Publicado: (2020)

S78. TIME PREDICTION AND SENSE OF SELF: LACK OF FLEXIBILITY IN PATIENTS WITH SCHIZOPHRENIA
por: Giersch, Anne, et al.
Publicado: (2020)

S16. INDEPENDENT SUPPORT FOR CORTICOPALLIDAL CONTRIBUTIONS TO SCHIZOPHRENIA-RELATED FUNCTIONAL IMPAIRMENT
Publicado: (2020)

S50. COGNITION AND EMOTION REGULATION IN SCHIZOPHRENIA PATIENTS WITH A HISTORY OF AGGRESSION
por: Ahmed, Anthony, et al.
Publicado: (2020)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

S184. IN SILICO PREDICTION OF T-CELL-MEDIATED MOLECULAR MIMICRY IN TOXOPLASMOSIS AND SCHIZOPHRENIA
por: Thylur, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sugosegh52nnnvspb6eb5jp2ua